These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12438901

  • 1. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis.
    Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA.
    Sex Transm Dis; 2002 Nov; 29(11):655-64. PubMed ID: 12438901
    [Abstract] [Full Text] [Related]

  • 2. Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.
    Zeitlin L, Hoen TE, Achilles SL, Hegarty TA, Jerse AE, Kreider JW, Olmsted SS, Whaley KJ, Cone RA, Moench TR.
    Sex Transm Dis; 2001 Jul; 28(7):417-23. PubMed ID: 11460027
    [Abstract] [Full Text] [Related]

  • 3. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ, Uckun FM.
    Curr Pharm Des; 2004 Jul; 10(3):315-36. PubMed ID: 14754390
    [Abstract] [Full Text] [Related]

  • 4. Reducing the risk of Chlamydia trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals.
    Lyons JM, Ito JI.
    Clin Infect Dis; 1995 Oct; 21 Suppl 2():S174-7. PubMed ID: 8845448
    [Abstract] [Full Text] [Related]

  • 5. Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission.
    Cone RA, Hoen T, Wong X, Abusuwwa R, Anderson DJ, Moench TR.
    BMC Infect Dis; 2006 Jun 01; 6():90. PubMed ID: 16740164
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model.
    Patton DL, Sweeney YC, Cummings PK, Meyn L, Rabe LK, Hillier SL.
    Sex Transm Dis; 2004 May 01; 31(5):290-6. PubMed ID: 15107631
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE, Zekeng L, Ryan KA, Tamoufé U, Weir SS, Wong EL.
    N Engl J Med; 1998 Aug 20; 339(8):504-10. PubMed ID: 9709043
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 0.25% chlorhexidine gluconate gel. A protective topical microbicide.
    Patton DL, Sweeney YT, McKay TL, DeMers SM, Clark AM, Rabe LK, Hillier SL.
    Sex Transm Dis; 1998 Sep 20; 25(8):421-4. PubMed ID: 9773435
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.
    Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B.
    Antiviral Res; 1999 Oct 20; 43(3):157-73. PubMed ID: 10551374
    [Abstract] [Full Text] [Related]

  • 13. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides.
    Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B.
    Antimicrob Agents Chemother; 2004 May 20; 48(5):1837-47. PubMed ID: 15105142
    [Abstract] [Full Text] [Related]

  • 14. Entry of inflammatory cells into the mouse vagina following application of candidate microbicides: comparison of detergent-based and sulfated polymer-based agents.
    Milligan GN, Dudley KL, Bourne N, Reece A, Stanberry LR.
    Sex Transm Dis; 2002 Oct 20; 29(10):597-605. PubMed ID: 12370527
    [Abstract] [Full Text] [Related]

  • 15. Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes.
    Krebs FC, Miller SR, Catalone BJ, Welsh PA, Malamud D, Howett MK, Wigdahl B.
    Antimicrob Agents Chemother; 2000 Jul 20; 44(7):1954-60. PubMed ID: 10858360
    [Abstract] [Full Text] [Related]

  • 16. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives.
    Fichorova RN, Bajpai M, Chandra N, Hsiu JG, Spangler M, Ratnam V, Doncel GF.
    Biol Reprod; 2004 Sep 20; 71(3):761-9. PubMed ID: 15128598
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.